Kumamoto, Japan

Ryoji Nagai

This inventor holds 1 USPTO granted patent. Top assignees: Riken Corporation, Tokai University Educational System. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ryoji Nagai. Retrieved from https://idiyas.com/inventor/ryoji-nagai

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ryoji Nagai: Innovator in Diabetic Complications Examination

Introduction

Ryoji Nagai is a notable inventor based in Kumamoto, Japan. He has made significant contributions to the field of medical diagnostics, particularly in examining diabetic complications. His innovative approach has the potential to improve the lives of many individuals affected by diabetes.

Latest Patents

Ryoji Nagai holds a patent for a method of examining diabetic complications. This patent includes a marker for examining a diabetic complication, represented by a specific compound formula. The method involves measuring the amount of this marker in a sample collected from a test subject and determining the presence or risk of developing diabetic complications based on the measurement results.

Career Highlights

Throughout his career, Ryoji Nagai has worked with esteemed institutions such as Tokai University Educational System and RIKEN Corporation. His work in these organizations has allowed him to collaborate with other experts in the field and contribute to advancements in medical research.

Collaborations

Ryoji Nagai has collaborated with Naoyuki Taniguchi, further enhancing his research and development efforts in the area of diabetic complications.

Conclusion

Ryoji Nagai's contributions to the examination of diabetic complications through his innovative patent highlight his dedication to improving medical diagnostics. His work continues to pave the way for advancements in the understanding and management of diabetes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…